Cyclophosphamide-induced urticaria. Occurrence in a patient with no cross-sensitivity to chlorambucil.
A patient receiving adjuvant chemoimmunotherapy for breast carcinoma developed urticaria secondary to cyclophosphamide, one of the drugs of the chemotherapy regimen. Chlorambucil, another alkylating agent, was substituted with no cross-sensitivity noted.
D001943:Breast Neoplasms / Q000188:drug therapy; D002699:Chlorambucil / Q000627:therapeutic use*; D003429:Cross Reactions; D003520:Cyclophosphamide / Q000009:adverse effects* / Q000627:therapeutic use; D004342:Drug Hypersensitivity / Q000209:etiology; D005260:Female; D006801:Humans; D008875:Middle Aged; D014581:Urticaria / Q000139:chemically induced*
D002699:Chlorambucil; D003520:Cyclophosphamide